Deutsche Bank’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Deutsche Bank’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,550	Closed	-$1.06M	–	3734
2024 Q1	$1.06M	Hold	50,550	–	–	﹤0.01%	1989
2023 Q4	$1.3M	Sell	50,550 -40,000	-44%	-$749K	﹤0.01%	1885
2023 Q3	$1.65M	Hold	90,550	–	–	﹤0.01%	1451
2023 Q2	$1.43M	Buy	90,550 +41	+0%	+$865	﹤0.01%	1788
2023 Q1	$2.17M	Buy	90,509 +18,978	+27%	+$379K	﹤0.01%	1650
2022 Q4	$1.22M	Hold	71,531	–	–	﹤0.01%	1929
2022 Q3	$1.08M	Hold	71,531	–	–	﹤0.01%	1912
2022 Q2	$1.27M	Hold	71,531	–	–	﹤0.01%	2022
2022 Q1	$1.37M	Hold	71,531	–	–	﹤0.01%	2136
2021 Q4	$1.77M	Hold	71,531	–	–	﹤0.01%	2073
2021 Q3	$1.55M	Hold	71,531	–	–	﹤0.01%	2310
2021 Q2	$2.11M	Buy	71,531 +1,295	+2%	+$37.1K	﹤0.01%	2174
2021 Q1	$1.94M	Hold	70,236	–	–	﹤0.01%	2195
2020 Q4	$2.36M	Sell	70,236 -4,000	-5%	-$122K	﹤0.01%	1829
2020 Q3	$1.78M	Sell	74,236 -764	-1%	-$17.8K	﹤0.01%	1826
2020 Q2	$1.74M	Buy	+75,000	New	+$1.49M	﹤0.01%	1888

Other funds holding CALT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCMC

Planning Capital Management Corporation Paoli, Pennsylvania $151M AUM 30.62% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank's CALT Position: Q2 2024 in Review

Deutsche Bank sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2024, closing a stake of 50,550 shares — an estimated $1.06M sold.

Deutsche Bank first reported a position in CALT in Q2 2020 and held it in 16 quarters. The position peaked at $2.36M in Q4 2020. 18 funds tracked by Wall St. Rank hold CALT as of Q2 2024.

Deutsche Bank reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2024 after selling out during the quarter.
Deutsche Bank sold 50,550 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2024, an estimated $1.06M.
Deutsche Bank first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 16 quarters.
Deutsche Bank's Calliditas Therapeutics AB American Depositary Shares position peaked at $2.36M in Q4 2020.
18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.